- Global Pharma News & Resources

North America Dominates Chylothorax Pleural Catheters With A Healthy CAGR of 6.4% Over The Next 10 Years

According to Fact.MR’s Study, Global Sales of Pleural catheters was valued at US$ 22.6 Mn in 2018, and is expected to witness a healthy CAGR of 6.4% during the forecast period (2019 – 2029).

The use of pleural catheters is gathering momentum globally owing to its proven efficacy as a treatment solution for malignant pleural effusions when pleurodesis has failed or is contraindicated. Pleural catheters are being used as a frontline therapy in order to improve patient quality of life, patient safety and clinician efficiency. Freedom from hospital admissions and effective symptomatic relief with minimum interventions are some of the critical factors propelling the growth of the pleural catheters market.

To remain ‘ahead’ of your competitors, request for a sample

“Significant morbidity reduction, prompt hospital discharge, less risk of re-intervention coupled with same-day outpatient procedures, performed by home healthcare provider or a trained family member are the key factors which paves the way for frontline therapy for pleural infection patients” says the Fact.MR Analyst

Pleural catheters have gained clinical significance on the back of their effective fluid control and improved dyspnea, affordability and its efficacy as a minimally invasive procedure. Outpatient procedures, reduction in associated risk, cost and hospitalization have prompted the expansion of the pleural catheters market. Moreover, inclination towards the use of pleural catheters, growing prevalence of pleural effusion and rising cases of COPD in emerging regions are the factors driving the market growth.

Key Takeaways of Pleural Catheters Market Study

  • Malignant Pleural Effusions emerged as the largest segment by indication type representing 75% of revenue share in the pleural catheters market. This is attributed to the viable alternative management strategy and its most frequently utilization in the clinical management of pleural infection, both malignant and benign effusion
  • Hospitals accounted for a majority of the revenue share of 65% owing to the availability of pleural catheters and skilled personnel for better clinical management of patients with pleural infection
  • Cumulatively, North America and Europe contribute more than 60% of market share in pleural catheters market with North America holding a noteworthy market share and the regional market is expected to grow at a CAGR of 7.3% during the forecast period
  • Increasing number of thoracic surgeries performed are increasing prevalence of pleural diseases and thus giving an uptick to the demand for pleural catheters.

Speak To Research Analyst For Detailed Insights:

Key Segments of Pleural catheters Market

  • Malignant Pleural Effusions
  • Non-Malignant Recurrent Effusions
  • Chylothorax
  • Empyema
  • Haemothorax
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

The study also includes statistics as well as facts related to macroeconomic as well as microeconomic factors that are impacting key developments in the market. It also offers actionable insights based on the future trends in the pleural catheters market. Furthermore, small businesses and new entrants in the pleural catheters market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

For critical insights on this market, request for methodology here-

Key Questions Answered in Fact.MR Pleural catheters Market Report

Which regions will continue to remain the most profitable regional markets for pleural catheters market players?
Which factors will induce a change in the demand for pleural catheter manufacturers during the assessment period?
How will changing trends impact the pleural catheters market?
How can market players capture the low-hanging opportunities in the pleural catheters market in developed regions?
Which companies are leading the pleural catheters market?
What are the winning strategies of stakeholders in the pleural catheters market to upscale their position in this landscape?

Pleural Catheters Manufacturers Strategically Focus on New Product Launches

Continuous upgradation and product launches in pleural catheters market are responsible for intense competition among the market players. Numerous organizations are focusing on new product approvals for pleural catheters. For example, in February 2018, Merit Medical launched Aspira® Drainage System which is a tunneled, long-term catheter used to drain accumulated fluid from the pleural or peritoneal cavity to relieve symptoms associated with malignant pleural effusion or malignant ascites. The system allows patients to drain fluid and manage their symptoms without repeated trips to the hospital. These winning strategies by leading players are also followed by regional and local players.

For More Insights

Looking for more information?

The research study on the pleural catheters market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the pleural catheters market over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence during 2019 – 2029. Market statistics have been presented on the basis of indication (Malignant Pleural Effusions, Non-Malignant Recurrent Effusions, Chylothorax, Empyema, Haemothorax), and end user (hospitals and ambulatory surgical centers) across major countries of key regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583 Corporate Headquarter: Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates Email:
Visit Our Website: Press Release:

Editor Details

Last Updated: 27-Aug-2021